|26.44||-0.90 / -3.29%|
Data as of 4:14pm ET
|26.43||-0.0053 / -0.02%|
The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 45.00, with a high estimate of 52.00 and a low estimate of 40.00. The median estimate represents a +70.20% increase from the last price of 26.44.
The current consensus among 6 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.